FDA panel
Healthcare
FDA Panel Backs New COVID Vaccines for JN.1 Variant by Fall
An expert panel from the Food and Drug Administration (FDA) voted unanimously on Wednesday to develop new COVID-19 vaccines specifically targeting the JN.1...
